Cargando…

Metronomic chemotherapy for indolent T‐cell lymphoproliferative disorder of the gastrointestinal tract

The present study proposes metronomic chemotherapy (CPT), including prednisolone, cyclophosphamide, and thalidomide, as a treatment for patients with severe symptomatic indolent T‐cell lymphoproliferative disorder of the gastrointestinal tract. The encouraging efficacy and excellent safety profile o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hailing, Cao, Lei, Zhao, Xiaoli, Miao, Yi, Wu, Wei, Shi, Xiao, Zhang, Xiaoyan, Yin, Hua, Zhu, Huayuan, Xu, Wei, Li, Jianyong, Fan, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	LETTER TO THE EDITOR
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475756/ https://www.ncbi.nlm.nih.gov/pubmed/37340510 http://dx.doi.org/10.1111/cas.15880

Ejemplares similares

Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract
por: Soderquist, Craig R., et al.
Publicado: (2020)

Indolent T-Cell Lymphoproliferative Disorders of the Gastrointestinal Tract (iTLPD-GI): A Review
por: Sanguedolce, Francesca, et al.
Publicado: (2021)

Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a tricky diagnosis of a gastric case
por: Zanelli, Magda, et al.
Publicado: (2020)

CD8-positive indolent T-Cell lymphoproliferative disorder of the gastrointestinal tract: A case report and review of literature
por: Weng, Chun-Yan, et al.
Publicado: (2022)

Indolent T-Cell Lymphoproliferative Disease: A Rare Case of a Benign Lymphoma of the Gastrointestinal Tract With Extra-Gastrointestinal Involvement
por: David, Robin, et al.
Publicado: (2022)

Indolent T-Cell Lymphoproliferative Disease of the GI Tract: Insights for Better Diagnosis, Prognosis, and Appropriate Therapy
por: Küçük, Can, et al.
Publicado: (2020)

Benign Indolent CD56-Positive NK-Cell Lymphoproliferative Lesion Involving Gastrointestinal Tract in an Adolescent
por: Koh, Jaemoon, et al.
Publicado: (2014)

An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow
por: Wang, Xingen, et al.
Publicado: (2018)

Metronomic chemotherapy
por: Maiti, Rituparna
Publicado: (2014)

Metronomic Chemotherapy
por: Cazzaniga, Marina Elena, et al.
Publicado: (2021)

Can a rational design for metronomic chemotherapy dosing be devised?
por: Maraveyas, A, et al.
Publicado: (2005)

Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
por: Dickinson, P D, et al.
Publicado: (2012)

Primary Gastrointestinal T-Cell Lymphoma and Indolent Lymphoproliferative Disorders: Practical Diagnostic and Treatment Approaches
por: Nishimura, Midori Filiz, et al.
Publicado: (2021)

A simplified prognostic score for T-cell large granular lymphocyte leukaemia
por: Liu, Hailing, et al.
Publicado: (2023)

Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
por: Khan, O A, et al.
Publicado: (2012)

Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients
por: Jung, Yun Hwa, et al.
Publicado: (2017)

Metronomic Chemotherapy in Prostate Cancer
por: Wysocki, Piotr J., et al.
Publicado: (2022)

Metronomic regimen as an effective treatment for aggressive T-LGL leukemia with central nervous system infiltration: clinical experience and review of literature
por: Liu, Yun, et al.
Publicado: (2017)

Tislelizumab with gemcitabine and oxaliplatin in patients with relapsed or refractory classic Hodgkin lymphoma: a multicenter phase II trial
por: Ding, Kaiyang, et al.
Publicado: (2023)

Head and neck cancer: metronomic chemotherapy
por: De Felice, Francesca, et al.
Publicado: (2015)

Epstein-Barr Virus Positive B-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
por: Ishikawa, Eri, et al.
Publicado: (2021)

Indolent T-cell lymphoproliferative disorder of the stomach successfully treated by radiotherapy
por: Takahashi, Naoki, et al.
Publicado: (2020)

Metronomic chemotherapy: changing the paradigm that more is better
por: Scharovsky, O.G., et al.
Publicado: (2009)

Response assessment in metronomic chemotherapy: RECIST or PERCIST?
por: Agrawal, Archi, et al.
Publicado: (2014)

Metronomic palliative chemotherapy in maxillary sinus tumor
por: Patil, Vijay M., et al.
Publicado: (2016)

Metronomic chemotherapy for triple negative breast cancer?
por: Di Desidero, Teresa, et al.
Publicado: (2016)

First-Line Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: A Systematic Analysis and Treatment Recommendation
por: Liu, Hailing, et al.
Publicado: (2022)

Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencing
por: Parker, Jeremy D.K., et al.
Publicado: (2016)

Low‐dose metronomic chemotherapy improves tumor control in nasopharyngeal carcinoma
por: Chen, Yu‐Pei, et al.
Publicado: (2022)

Allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders
por: Fonseca-Hial, Ana Marcela Rojas, et al.
Publicado: (2016)

A case of lymphoproliferative disorder of NK-cells: aggressive immunophenotype but indolent behavior
por: Shi, Min, et al.
Publicado: (2015)

Post-transplantation lymphoproliferative disorder with gastrointestinal involvement
por: Inayat, Faisal, et al.
Publicado: (2018)

Transabdominal Ultrasonographic Findings of Gastrointestinal Lymphoproliferative Disease
por: Takahara, Masahiro, et al.
Publicado: (2019)

Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis
por: Yi, Shuhua, et al.
Publicado: (2020)

Use of metronomic chemotherapy in the management of a cat with abdominal haemangiosarcoma
por: Yee-Ka Cheng, Katrina, et al.
Publicado: (2018)

Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy
por: Maharjan, Ruby, et al.
Publicado: (2019)

Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
por: Perroud, Herman Andrés, et al.
Publicado: (2017)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2017)

Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience
por: Simsek, Cem, et al.
Publicado: (2019)

Metronomic Chemotherapy for Palliative Treatment of Malignant Oral Tumors in Dogs
por: Milevoj, Nina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ti7d00u3q3e33sfkaeqv9bcu5q